Loading...
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
BACKGROUND: For patients with recurrent glioblastoma (rGBM), there are few options following treatment failure with radiotherapy plus temozolomide. Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of the TGF-βRII receptor (a TGF-β “trap”) fused to...
Na minha lista:
| Udgivet i: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8156979/ https://ncbi.nlm.nih.gov/pubmed/34056607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab058 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|